InsideArbitrage Event Driven Monitor – February 8, 2024

Merger Arbitrage

1. MOR: MorphoSys (MOR) disclosed a definitive merger agreement outlining termination fee specifics. In the event of a termination, Novartis would be liable to pay MorphoSys EUR 100 million, while MorphoSys would incur a EUR 50 million fee payable to Novartis.
2. AXNX: Axonics (AXNX) and Boston Scientific (BSX) filed notification and report forms under the HSR Act with the DOJ and the FTC on January 30, 2024.
3. PXD: Pioneer Natural Resources Company (PXD) announced that the company received shareholder approval for the pending merger with Exxon Mobil Corporation (XOM).

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.